
views
Directa Plus – trading warning. How much faith to have in its stated 2023 confidence?
Previously writing on company describing itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets” Directa Plus (DCTA), in October with the shares up to 89.5p I concluded that its recent announcements and above £59 million market cap meant that I retained caution, still avoid/sell. The shares last closed at 83.8p but are currently falling well below 80p on the back of a “trading update”.
- By Steve Moore
- 2022-12-02 14:03:00